Primary Insomnia

82 registered clinical trials studyying Primary Insomnia — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Comparative Efficacy of Magnesium Supplement and Melatonin Congener in Young Adults With Primary Insomnia NCT06996171	CMH Kharian Medical College	N/A
Not Yet Recruiting	Brisk Walking Training Compared with Cognitive Behavioral Therapy for the Treatment of Chronic Primary Insomni NCT06850272	Chinese University of Hong Kong	N/A
Not Yet Recruiting	Enhancing Sleep Onset: the Power of Tactile Breath Pacer in Cognitive Behavioral Therapy for Insomnia NCT06475378	Vrije Universiteit Brussel	N/A
Recruiting	Acupoint Selection Based on Meridian Theory in Primary Insomnia of Liver Depression and Spleen Deficiency Type NCT06782815	Chuanlong Zhou	N/A
Recruiting	The Study on the Evaluation of Acupuncture Therapy on Primary Insomnia NCT05830877	The Third Affiliated hospital of Zhejiang Chinese Medical University	N/A
Completed	The Effects of Milk and Banana as a Night Meal to Primary Insomnia on Sleep Quality, BDNF and Appetite Mechani NCT05420090	Saglik Bilimleri Universitesi	N/A
Completed	Digital Cognitive Behavioral Therapy for Insomnia in China NCT05416346	Peking University	N/A
Completed	Better Nights, Better Days for Children With Neurodevelopment Disorders NCT02694003	IWK Health Centre	N/A
Terminated	Comparison of Efficacy of Behavioral Approaches for Treatment of Insomnia NCT03461666	Pacific Institute of Medical Sciences	N/A
Completed	Evaluation of a Group Therapeutic Exercise Program NCT03542396	University Hospital Tuebingen	N/A
Completed	Effects of Regular Practice of Yoga on Subjective and Objective Sleep Quality in Primary Insomnia NCT03314441	Centre Hospitalier Universitaire Saint Pierre	N/A
Completed	Better Nights, Better Days for Typically Developing Children NCT02243501	IWK Health Centre	N/A
Completed	Effect of Transcranial Direct-current Stimulation Therapy on Primary Chronic Insomnia Patients NCT02832804	Seoul National University Hospital	N/A
Completed	Improving Sleep Quality in People With Insomnia NCT02443649	Oregon Health and Science University	N/A
Unknown	Different Acupoints Compatibility Difference of the Effect of Treatment of the Primary Insomnia NCT02448602	Changchun University of Chinese Medicine	Phase 1
Completed	Impact of Hyperarousal on Simple and Complex Cognitive Task Performance Among Insomnia Sufferers NCT02290405	Jack Edinger, PhD	—
Unknown	Enhancing Performance of Cognitive Behavioral Therapy for Insomnia With an Integrative Mobile Platform NCT01978626	National Taiwan University Hospital	N/A
Completed	Auricular Acupuncture for Primary Insomnia NCT02087488	Chengdu University of Traditional Chinese Medicine	N/A
Completed	Metabolomics of Insomnia-Related Hyperarousal NCT01957111	University of Pennsylvania	—
Completed	A High Density EEG Comparison of Sleep Patterns in Insomnia NCT01960452	University of Wisconsin, Madison	—
Completed	30 Days in Home Use and Home Use Patterns Over 6 Months NCT01882699	Cereve, Inc.	N/A
Completed	Two Contrasting Interventions for Sleep Management NCT01804036	University of Utah	Phase 2 / Phase 3
Completed	Efficacy and Safety of 5 mg Sublingual Zolpidem vs 10mg Oral Zolpidem in the Induction and Maintenance of Slee NCT01896336	EMS	Phase 4
Completed	Comparison of Two Temperatures to Treat Insomnia NCT01790256	Cereve, Inc.	N/A
Completed	Neurophysiologic Correlates of Hypersomnia NCT01719315	University of Wisconsin, Madison	—
Completed	CBT Versus a Return to Work Intervention for Patients With Common Mental Illness in Primary Care NCT01636791	Karolinska Institutet	Phase 3
Completed	CBT vs RTW Intervention for Patients With Common Subclinical Mental Illness in Primary Care NCT01667809	Karolinska Institutet	Phase 3
Completed	Cognitive Behavioral Therapy, Guided Self Help Versus Individual Therapy NCT01667822	Karolinska Institutet	Phase 3
Completed	Sequenced Therapies for Comorbid and Primary Insomnias NCT01651442	Jack Edinger, PhD	N/A
Unknown	Exploratory Study of Effective Core Formula of Chinese Medicine to Treat Primary Insomnia NCT01613183	China Academy of Chinese Medical Sciences	N/A
Completed	Sleep Laboratory Study to Investigate the Safety and Efficacy of Neu-P11 in Primary Insomnia Patients NCT01489969	Neurim Pharmaceuticals Ltd.	Phase 2
Completed	Mindfulness and RelaxationTraining for Insomnia (MRTI) on Postmenopausal Women: a Randomized Clinical Trial. NCT01593436	University of Sao Paulo	N/A
Completed	Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study A (MK-4305-028) NCT01097616	Merck Sharp & Dohme LLC	Phase 3
Completed	Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study B (MK-4305-029) NCT01097629	Merck Sharp & Dohme LLC	Phase 3
Completed	Study of Sleep-maintenance Activity of 3 Doses of SKP-1041 NCT00878553	Somnus Therapeutics, Inc.	Phase 2
Completed	Polysomnography Study of MK-6096 in Participants With Primary Insomnia (MK-6096-011) NCT01021852	Merck Sharp & Dohme LLC	Phase 2
Completed	A Study to Compare Efficacy and Safety of Zolpidem Modified Release Formulation Versus Zolpidem in Insomnia Pa NCT01181232	Astellas Pharma Inc	Phase 4
Completed	A Study to Evaluate Efficacy and Safety of Zolpidem Modified Release Formulation in Insomnia Patients NCT00956319	Astellas Pharma Inc	Phase 4
Completed	Acupuncture for the Treatment of Insomnia NCT00855140	University of Pittsburgh	N/A
Completed	Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties NCT00805350	Sanofi	Phase 3
Completed	Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006) NCT00792298	Merck Sharp & Dohme LLC	Phase 2
Completed	An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia NCT00784875	Eli Lilly and Company	Phase 2
Completed	A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126) NCT00770510	Eisai Co., Ltd.	Phase 2 / Phase 3
Completed	Chamomile for Chronic Primary Insomnia NCT01286324	University of Michigan	Phase 2
Completed	Information Processing at Sleep Onset and During Sleep in Patients With Insomnia NCT00680199	University of Rochester	—
Terminated	Efficacy and Safety Study of Adipiplon, Placebo and an Active Control in Primary Insomniacs NCT00683436	Neurogen Corporation	Phase 2
Completed	Subjective Study to Assess the Efficacy of APD125 in Patients With Sleep Maintenance Insomnia NCT00664664	Arena Pharmaceuticals	Phase 2
Completed	Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia NCT00608985	Midnight Pharma, LLC	Phase 3
Completed	The Psychoneuroimmunology of Insomnia NCT00680771	University of Rochester	—
Completed	VEC-162 Study in Adult Patients With Primary Insomnia NCT00548340	Vanda Pharmaceuticals	Phase 3
Completed	A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia NCT00551148	Pfizer	Phase 2
Completed	A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys NCT00520832	Logan College of Chiropractic	Phase 2
Completed	Mindfulness Versus Pharmacotherapy for Chronic Insomnia: A Pilot Study NCT00515177	University of Minnesota	Phase 2 / Phase 3
Completed	Quetiapine for Primary Insomnia Patients : A Randomized Controlled Trial NCT00328822	Khon Kaen University	N/A
Terminated	How do Sleeping Pills Affect Pain in the Brain? NCT00414037	University of California, San Diego	Phase 4
Completed	Efficacy and Safety of Circadin® 2 mg in the Treatment of Primary Insomnia Patients NCT00397189	Neurim Pharmaceuticals Ltd.	Phase 3
Unknown	Safety and Efficacy of an Ambulatory Biofeedback Device for Primary Insomnia NCT00415714	Helicor	N/A
Terminated	Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED) NCT00420810	H. Lundbeck A/S	Phase 3
Completed	Study of the Insomnia in Patients With Low Back Pain NCT00365976	Duke University	Phase 4
Completed	The Role of Partial Reinforcement in the Long Term Management of Insomnia NCT00662155	University of Pennsylvania	N/A
Completed	Almorexant in Primary Insomnia NCT00640848	Midnight Pharma, LLC	Phase 1
Completed	Sleep Loss and Mechanisms of Impaired Glucose Metabolism NCT00555750	Brigham and Women's Hospital	N/A
Completed	Safety and Efficacy of Chronic Hypnotic Use NCT01006525	Henry Ford Health System	—
Completed	Sleep Homeostasis in Primary Insomnia NCT00256503	University of Rochester	N/A
Terminated	Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED) NCT00266357	H. Lundbeck A/S	Phase 2
Completed	MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED) NCT00266344	H. Lundbeck A/S	Phase 2
Completed	Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability NCT00368056	Sumitomo Pharma America, Inc.	Phase 3
Completed	Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing NCT00156533	University of Rochester	Phase 4
Completed	The Effects of Modafinil on Waking Function and on Sleep in Individuals With Primary Insomnia NCT00124384	University of Rochester	Phase 4
Completed	Testing the Nocturnal Sleep Latency Profile in Primary Insomnia NCT00167375	University of Pittsburgh	—
Terminated	Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED) NCT00094666	H. Lundbeck A/S	Phase 3
Completed	Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED) NCT00094627	H. Lundbeck A/S	Phase 3
Completed	A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia NCT00209950	H. Lundbeck A/S	Phase 3
Completed	A Study of Gaboxadol in Primary Insomnia NCT00209846	H. Lundbeck A/S	Phase 3
Completed	A Study of Gaboxadol in Primary Insomnia NCT00209924	H. Lundbeck A/S	Phase 3
Completed	6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia NCT00352144	Sumitomo Pharma America, Inc.	Phase 3
Completed	A Study of Gaboxadol in Primary Insomnia NCT00209963	H. Lundbeck A/S	Phase 3
Completed	A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia NCT00209937	H. Lundbeck A/S	Phase 3
Completed	Behavioral Insomnia Therapy in Primary Care NCT00105872	US Department of Veterans Affairs	N/A
Completed	Twelve Month Study of the Safety of Eszopiclone in Adult Subjects With Insomnia NCT01710631	Sumitomo Pharma America, Inc.	Phase 3
Completed	Paroxetine in the Treatment of Chronic Primary Insomnia NCT00178048	University of Pittsburgh	Phase 4
Completed	Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs NCT00816673	Neurim Pharmaceuticals Ltd.	Phase 2